相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
Kankan Wang et al.
CANCER CELL (2010)
Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells
A. Puissant et al.
LEUKEMIA (2010)
Identification of AML1-ETO modulators by chemical genomics
Steven M. Corsello et al.
BLOOD (2009)
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
Bas J. Wouters et al.
BLOOD (2009)
EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function
Leopoldo Laricchia-Robbio et al.
CANCER RESEARCH (2009)
Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions
Brice Korkmaz et al.
BIOCHIMIE (2008)
t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko J. Okumura et al.
BLOOD (2008)
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
Michael H. Tomasson et al.
BLOOD (2008)
The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation
Edgar Wingender
BRIEFINGS IN BIOINFORMATICS (2008)
AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
Alessandro Gardini et al.
PLOS GENETICS (2008)
Repression of RUNX1 activity by EVI1: A new role of EVI1 in leukemogenesis
Vitalyi Senyuk et al.
CANCER RESEARCH (2007)
Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo
Guang-Biao Zhou et al.
BLOOD (2007)
Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-κB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner
L. Wang et al.
CELL DEATH AND DIFFERENTIATION (2007)
Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein
G. Yang et al.
ONCOGENE (2007)
Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia
Sutisak Kitareewan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts
J. Dunne et al.
ONCOGENE (2006)
Neutrophil serine proteases: specific regulators of inflammation
Christine T. N. Pham
NATURE REVIEWS IMMUNOLOGY (2006)
ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO
J Lausen et al.
ONCOGENE (2006)
The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding
A Lennartsson et al.
GENE (2005)
Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α
Y Jiang et al.
LEUKEMIA (2005)
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion
JC Mulloy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A T lymphocyte-specific transcription complex containing RUNX1 activates MHC class I expression
TK Howcroft et al.
JOURNAL OF IMMUNOLOGY (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Comprehensive analysis of CBFβ-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis
SS Kadkol et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Williams-Beuren syndrome critical region-5/non-T-cell activation linker:: a novel target gene of AML1/ETO
M Fliegauf et al.
ONCOGENE (2004)
The 8; 21 translocation in leukemogenesis
LF Peterson et al.
ONCOGENE (2004)
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
JC Mulloy et al.
BLOOD (2003)
Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice
AA Lane et al.
CELL (2003)
Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism
L McGhee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells
O Heidenreich et al.
BLOOD (2003)
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia
RK Vangala et al.
BLOOD (2003)
The t(8;21) fusion protein, AML1-ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia
B Linggi et al.
NATURE MEDICINE (2002)
Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis
H Shimada et al.
LEUKEMIA (2002)
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia
M Higuchi et al.
CANCER CELL (2002)
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
JC Mulloy et al.
BLOOD (2002)
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
JD Licht
ONCOGENE (2001)
The human brm protein is cleaved during apoptosis: The role of cathepsin G
JR Biggs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
